Product Description
Novorapid Penfill (3ml Each) is used for blood sugar control in people with type 1 and type 2 diabetes mellitus. It is a fast-acting type of insulin that helps to lower blood sugar levels after meals and reduce the chances of developing serious complications of diabetes.Rapid Onset and Peak EffectNovorapid Penfill Injection is formulated to begin acting within 10 to 20 minutes post-injection, delivering a peak effect between 1 to 3 hours for prompt glycemic control. Its duration of action typically spans 3 to 5 hours, making it ideal for managing postprandial blood glucose spikes in diabetes patients.
Compatibility and ConveniencePackaged in easy-to-use 3 ml penfill cartridges, Novorapid is compatible with most insulin delivery devices, facilitating accurate and comfortable administration. This practical design supports both adults and children in efficiently integrating insulin therapy into their daily routines.
Storage and Safety PrecautionsMaintain Novorapid Penfill Injection in refrigeration (2C to 8C), avoiding freezing to preserve its efficacy. Adhere strictly to physician-prescribed dosages and usage instructions. Each box contains 5 penfill cartridges, supporting treatment continuity and convenient stock management for users and healthcare providers.
FAQ's of Novorapid Penfill Injection:
Q: How should Novorapid Penfill Injection be administered?
A: Novorapid Penfill Injection is intended for subcutaneous (under the skin) administration. It should be injected before meals, using an appropriate insulin delivery device. Follow your physician's specific instructions for dosing and site rotation to achieve optimal blood glucose control.
Q: What are the benefits of using Novorapid Penfill Injection for diabetes management?
A: This rapid-acting insulin helps control blood sugar spikes after meals in both type 1 and type 2 diabetes. Quick onset and peak action times allow for flexible dosing around meals, supporting better glycemic management and reducing the risk of long-term complications associated with uncontrolled diabetes.
Q: When does Novorapid Penfill Injection start working after administration?
A: Novorapid begins to lower blood glucose levels within 10 to 20 minutes after injection. Its peak activity typically occurs between 1 and 3 hours, and its overall duration of action is about 3 to 5 hours.
Q: Where should I store Novorapid Penfill Injection cartridges?
A: Store Novorapid Penfill cartridges in a refrigerator at a temperature between 2C and 8C. Do not freeze the cartridges, as freezing can reduce the effectiveness of the insulin. Keep the medication out of direct sunlight and use within 24 months from the manufacturing date.
Q: What precautions should be taken while using Novorapid Penfill Injection?
A: Always use Novorapid as prescribed by your physician. Check the solution before use; it should be clear and colorless. Rotate injection sites to prevent skin problems, and never use the medication if it has been frozen or shows signs of particulate matter. Monitor your blood sugar regularly to guide ongoing treatment.
Q: Is Novorapid suitable for all age groups?
A: Yes, Novorapid Penfill Injection is suitable for both adults and children with diabetes mellitus. However, individualized dosing and administration should always be supervised by a healthcare professional for safe and effective use.